Hypoxia inducible factor and hypoxia-mediated pulmonary hypertension

PVRI Review

Volumn 3, Issue 1, 2011, Pages 5-11

  Østergaard, Louise ^a   Gassmann, Max ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

HIF 1; Hypoxia; pulmonary hypertension; transcription factors

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; HYPOXIA INDUCIBLE FACTOR 2BETA; HYPOXIA INDUCIBLE FACTOR 3ALPHA; HYPOXIA INDUCIBLE FACTOR 3BETA; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ALPHA CHAIN; ANGIOGENESIS; BETA CHAIN; CELL PROLIFERATION; CLINICAL FEATURE; DNA BINDING; DOWN REGULATION; ENDOTHELIAL PAS DOMAIN PROTEIN 1 GENE; ERYTHROPOIETIN GENE; GENE; GENE EXPRESSION REGULATION; GENE TARGETING; GENE TRANSLOCATION; GENETIC VARIABILITY; HUMAN; HYPOXIA; LUNG CIRCULATION; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY HYPERTENSION; REVIEW; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 80054749164     PISSN: 09746013     EISSN: 09751602     Source Type: Journal    
DOI: 10.4103/0974-6013.85613     Document Type: Review

References (75)

1. Weissmann N, Sommer N, Schermuly RT, Ghofrani HA, Seeger W, Grimminger F. Oxygen sensors in hypoxic pulmonary vasoconstriction. Cardiovasc Res 2006;71:620-9. (Pubitemid 44848000)
2. McLaughlin VV, Rich S. Severe pulmonary hypertension: Critical care clinics. Crit Care Clin 2001;17:453-67. (Pubitemid 32612724)
3. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure: The role of the endothelium in pathophysiology and management. Circulation 2000;102: 1718-23.
4. Dumas JP, Bardou M, Goirand F, Dumas M. Hypoxic pulmonary vasoconstriction. Gen Pharmacol 1999;33:289-97. (Pubitemid 29465734)
5. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of infammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994;144:275-85. (Pubitemid 24165948)
6. Hirose S, Hosoda Y, Furuya S, Otsuki T, Ikeda E. Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension. Pathol Int 2000;50:472-9. (Pubitemid 30482392)
7. Sakao S, Taraseviciene-Stewart L, Lee JD, Wood K, Cool CD, Voelkel NF. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB J 2005;19:1178-80. (Pubitemid 40946457)
8. Goldberg MA, Dunning SP, Bunn HF. Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein. Science 1988;242:1412-5.
9. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA 1991;88:5680-4. (Pubitemid 21914809)
10. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992;12:5447-54.
11. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-pas heterodimer regulated by cellular o2 tension. Proc Natl Acad Sci USA 1995;92:5510-4.
12. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995;270:1230-7.
13. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002;16:1151-62. (Pubitemid 34815403)
14. Fandrey J, Gassmann M. Oxygen sensing and the activation of the hypoxia inducible factor 1 (HIF-1)-invited article. Adv Exp Med Biol 2009;648:197-206.
15. Wenger RH, Gassmann M. Oxygen(ES) and the hypoxia-inducible factor-1. Biol Chem 1997;378:609-16. (Pubitemid 27361853)
16. Hofman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA, et al. Cloning of a factor required for activity of the AH (Dioxin) receptor. Science 1991;252:954-8. (Pubitemid 21917012)
17. Gradin K, McGuire J, Wenger RH, Kvietikova I, Fhitelaw ML, Tofgard R, et al. Functional interference between hypoxia and dioxin signal transduction pathways: Competition for recruitment of the ARNT transcription factor. Mol Cell Biol 1996;16:5221-31. (Pubitemid 26315042)
18. Salceda S, Beck I, Caro J. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch Biochem Biophys 1996;334:389-94. (Pubitemid 26347323)
19. Wood SM, Gleadle JM, Pugh CW, Hankinson O, Ratclife PJ. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in arnt-defcient cells. J Biol Chem 1996;271:15117-23.
20. Chilov D, Camenisch G, Kvietikova I, Ziegler U, Gassmann M, Wenger RH. Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): Heterodimerization with ARNT is not necessary for nuclear accumulation of hif-1alpha. J Cell Sci 1999;112:1203-12. (Pubitemid 29218909)
21. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H, et al. Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/P300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J 1998;17:6573-86. (Pubitemid 28521792)
22. Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 1996;271:32253-9. (Pubitemid 26422262)
23. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, Gassmann M. Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J 2001;15:1312-4.
24. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an o2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998;95:7987-92.
25. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ. Activation of hypoxia-inducible factor-1: Defnition of regulatory domains within the alpha subunit. J Biol Chem 1997;272:11205-14. (Pubitemid 27184117)
26. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. Hifalpha targeted for vhl-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 2001;292:464-8. (Pubitemid 32335941)
27. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von hippel-lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468-72. (Pubitemid 32335942)
28. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001;294:1337-40. (Pubitemid 33063099)
29. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, et al. C. Elegans EGL-9 and mammalian homologs defne a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001;107:43-54. (Pubitemid 32972036)
30. Stebbins CE, Kaelin WG Jr, Pavletich N P. Structure of the vhl-elonginc-elonginb complex: Implications for VHL tumor suppressor function. Science 1999;284:455-61. (Pubitemid 29289612)
31. Maxwell PH, Wiesener MS, Chang GW, Cliford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-5. (Pubitemid 29246458)
32. Krek W. Vhl takes HIF's breath away. Nat Cell Biol 2000;2: E121-3.
33. Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC, Conaway JW. Activation of HIF1ALPHA ubiquitination by a reconstituted von hippel-lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA 2000;97:10430-5.
34. Harris AL. Hypoxia-key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47. (Pubitemid 37328806)
35. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-32. (Pubitemid 37328811)
36. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005;2005: re12.
37. Elvidge G P, Glenny L, Appelhof RJ, Ratclife PJ, Ragoussis J, Gleadle JM. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate- dependent dioxygenase inhibition: The role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 2006;281:15215-26. (Pubitemid 43855111)
38. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005;105:659-69. (Pubitemid 40070750)
39. Ortiz-Barahona A, Villar D, Pescador N, Amigo J, del Peso L. Genome-wide identifcation of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profling data and in silico binding site prediction. Nucleic Acids Res 2010;38:2332-45.
40. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y. A novel BHLH-pas factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 1997;94:4273-8.
41. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of diferent organs. FASEB J 2003;17:271-3.
42. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 1998;12:3320-4. (Pubitemid 28520979)
43. Scortegagna M, Ding K, Oktay Y, Gaur A, Thurmond F, Yan LJ, et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in EPAS1-/-mice. Nat Genet 2003;35:331-40. (Pubitemid 37486916)
44. Lando D, Pongratz I, Poellinger L, Whitelaw ML. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J Biol Chem 2000;275:4618-27. (Pubitemid 30108846)
45. Makino Y, Cao R, Svensson K, Bertilsson G, Asman M, Tanaka H, et al. Inhibitory pas domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001;414:550-4. (Pubitemid 33131538)
46. Makino Y, Kanopka A, Wilson WJ, Tanaka H, Poellinger L. Inhibitory pas domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus. J Biol Chem 2002;277:32405-8. (Pubitemid 34984738)
47. Heidbreder M, Frohlich F, Johren O, Dendorfer A, Qadri F, Dominiak P. Hypoxia rapidly activates HIF-3alpha MRNA expression. FASEB J 2003;17:1541-3.
48. Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH, Collen D, et al. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 2003;111:1519-27. (Pubitemid 38063284)
49. Beall CM, Cavalleri GL, Deng L, Elston RC, Gao Y, Knight J, et al. Natural selection on epas1 (HIF2ALPHA) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci USA 2010;107:11459-64.
50. Simonson TS, Yang Y, Huf CD, Yun H, Qin G, Witherspoon DJ, et al. Genetic evidence for high-altitude adaptation in Tibet. Science 2010;329:72-5.
51. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, et al. Impaired physiological responses to chronic hypoxia in mice partially defcient for hypoxia-inducible factor 1alpha. J Clin Invest 1999;103:691-6. (Pubitemid 29122422)
52. Hickey MM, Richardson T, Wang T, Mosqueira M, Arguiri E, Yu H, et al. The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice. J Clin Invest 2010;120:827-39.
53. Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK. Mitochondrial metabolism, redox signaling, and fusion: A Mitochondria-ROS-HIF- 1alpha-KV1.5 o2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008;294: H570-8. (Pubitemid 351253263)
54. Fialkowska I, Xu W, Comhair SA, Janocha AJ, Mavrakis LA, Krishnamachary B, et al. Hypoxia inducible-factor1alpha regulates the metabolic shif of pulmonary hypertensive endothelial cells. Am J Pathol 2010;176:1130-8.
55. Dessouroux A, Akwa Y, Baulieu EE. Dhea decreases hif-1alpha accumulation under hypoxia in human pulmonary artery cells: Potential role in the treatment of pulmonary arterial hypertension. J Steroid Biochem Mol Biol 2008;109:81-9.
56. Barer GR, Bee D, Wach RA. Contribution of polycythaemia to pulmonary hypertension in simulated high altitude in rats. J Physiol 1983;336:27-38. (Pubitemid 13153397)
57. Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M. Recombinant human erythropoietin (RHUEPO) increases endothelin-1 release by endothelial cells. Kidney Int 1993;43: 1010-4. (Pubitemid 23137084)
58. Vogel V, Kramer HJ, Backer A, Meyer-Lehnert H, Jelkmann W, Fandrey J. Efects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells. Am J Hypertens 1997;10:289-96. (Pubitemid 27128272)
59. Voelkel NF, Hoeper M, Maloney J, Tuder RM. Vascular endothelial growth factor in pulmonary hypertension. Ann N Y Acad Sci 1996;796:186-93. (Pubitemid 26405429)
60. Hanze J, Weissmann N, Grimminger F, Seeger W, Rose F. Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling. Thromb Haemost 2007;97:774-87. (Pubitemid 46779962)
61. Eddahibi S, Fabre V, Boni C, Martres MP, Rafestin B, Hamon M, et al. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res 1999;84:329-36. (Pubitemid 29095574)
62. Greier AE, van der Groep P, Kemming D, Shvarts A, Semenza GL, Meier GA, et al. Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 2005;206:291-304. (Pubitemid 40903193)
63. Coulet F, Nadaud S, Agrapart M, Soubrier F. Identifcation of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 2003;278:46230-40. (Pubitemid 37452193)
64. Palmer LA, Semenza GL, Stoler MH, Johns RA. Hypoxia induces type II nos gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol 1998;274: L212-9.
65. Steudel W, Ichinose F, Huang PL, Hurford WE, Jones RC, Bevan JA, et al. Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) Gene. Circ Res 1997;81:34-41. (Pubitemid 27272980)
66. Ozaki M, Kawashima S, Yamashita T, Ohashi Y, Rikitake Y, Inoue N, et al. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium. Hypertension 2001;37:322-7. (Pubitemid 32199094)
67. Ruschitzka FT, Wenger RH, Stallmach T, Quaschning T, de Wit C, Wagner K, et al. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 2000;97:11609-13.
68. Weissmann N, Manz D, Buchspies D, Keller S, Mehling T, Voswinckel R, et al. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia. Thromb Haemost 2005;94:630-8. (Pubitemid 41300862)
69. Zhang R, Wu Y, Zhao M, Liu C, Zhou L, Shen S, et al. Role of HIF-1alpha in the regulation ace and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am J Physiol 2009;297: L631-40.
70. Shimoda LA, Manalo DJ, Sham JS, Semenza GL, Sylvester JT. Partial HIF-1alpha defciency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol 2001;281: L202-8.
71. Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thebaud B, Bonnet S, et al. An abnormal mitochondrial-hypoxia inducible factor-1alpha-kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: Similarities to human pulmonary arterial hypertension. Circulation 2006;113:2630-41. (Pubitemid 43948012)
72. Shimoda LA, Fallon M, Pisarcik S, Wang J, Semenza GL. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular PH in pulmonary arterial myocytes. Am J Physiol 2006;291: L941-9. (Pubitemid 44772056)
73. Wang J, Weigand L, Lu W, Sylvester JT, Semenza GL, Shimoda LA. Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular CA2+ in pulmonary arterial smooth muscle cells. Circ Res 2006;98:1528-37. (Pubitemid 44297076)
74. Kaluz S, Kaluzova M, Stanbridge EJ. Regulation of gene expression by hypoxia: Integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clin Chim Acta 2008;395:6-13.
75. Rocha S. Gene regulation under low oxygen: Holding your breath for transcription. Trends Biochem Sci 2007;32:389-97. (Pubitemid 47126857)